Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Matthew Alexander Lunning, Julie Vose, Nathan Hale Fowler, Loretta J. Nastoupil, Marshall T. Schreeder, Tanya Siddiqi, Christopher Flowers, Jonathon Brett Cohen, Susan Blumel, Myra Miguel, Warner H Tse, Emily K. Pauli, Kathy Cutter, Peter Sportelli, Hari | ||||||||||||
Title | Ublituximab plus TGR-1202 activity and safety profile in relapsed/refractory B-cell NHL and high-risk CLL. | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/152562-156 | ||||||||||||
Abstract Text | J Clin Oncol 33, 2015 (suppl; abstr 8548) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|